The global Pharma Grade Dextrose Monohydrate market size is predicted to grow from US$ 451 million in 2025 to US$ 660 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

Dextrose monohydrate is a form of glucose commonly used in the pharmaceutical and food industries. It is a crystalline form of dextrose, which is a simple sugar (monosaccharide) derived from corn. Dextrose monohydrate is often used as a sweetener, a source of carbohydrate in intravenous fluids, and as a bulking agent in pharmaceuticals.

Pharma grade dextrose monohydrate is produced to meet the stringent quality standards required for pharmaceutical applications. It undergoes thorough purification processes to ensure it is free from impurities and contaminants, meeting the specifications set by pharmacopeias.

Increasing Healthcare Expenditure: As healthcare expenditure rises globally, the demand for pharmaceuticals and related products may increase, including ingredients like pharma grade dextrose monohydrate.

Growing Population and Health Awareness: The increasing global population and growing awareness of health issues can drive the demand for pharmaceutical products, which, in turn, affects the demand for pharmaceutical-grade ingredients.

Advancements in Medical Technology: Advances in medical technology may lead to the development of new pharmaceutical products, creating opportunities for suppliers of pharmaceutical-grade ingredients.

Regulatory Changes: Changes in regulations and quality standards can impact the production and distribution of pharmaceutical ingredients. Compliance with regulatory requirements is crucial for suppliers in this industry.

Global Health Crises: Events such as pandemics or other health crises can significantly impact the pharmaceutical industry. The demand for certain pharmaceutical products may increase during such events.

Infinity Market Research newest research report, the Pharma Grade Dextrose Monohydrate Industry Forecast looks at past sales and reviews total world Pharma Grade Dextrose Monohydrate sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharma Grade Dextrose Monohydrate sales for 2025 through 2031. With Pharma Grade Dextrose Monohydrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma Grade Dextrose Monohydrate industry.

This Insight Report provides a comprehensive analysis of the global Pharma Grade Dextrose Monohydrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharma Grade Dextrose Monohydrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Pharma Grade Dextrose Monohydrate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma Grade Dextrose Monohydrate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma Grade Dextrose Monohydrate.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharma Grade Dextrose Monohydrate market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Oral Grade
    Injection Grade

Segmentation by Application:

    Tablet
    Oral Liquid
    Injection
    Other

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Tereos
    Roquette
    Shandong Xiangrui Pharmaceutical
    Weifang Shengtai Pharmaceutical
    Qinhuangdao Lihua Starch
    Fengyuan Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharma Grade Dextrose Monohydrate market?
What factors are driving Pharma Grade Dextrose Monohydrate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharma Grade Dextrose Monohydrate market opportunities vary by end market size?
How does Pharma Grade Dextrose Monohydrate break out by Type, by Application?